Harry H. Mansbach - Jan 5, 2024 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role
Chief Medical Officer
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Harry H. Mansbach
Stock symbol
ETNB
Transactions as of
Jan 5, 2024
Transactions value $
-$111,507
Form type
4
Date filed
1/8/2024, 07:00 PM
Previous filing
Sep 12, 2023
Next filing
Feb 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETNB Common Stock Award $0 +25K +24.96% $0.00 125K Jan 5, 2024 Direct F1
transaction ETNB Common Stock Tax liability -$112K -9.67K -7.73% $11.53 115K Jan 5, 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents settlement by the Issuer of performance-based restricted stock units ("RSUs") granted to the Reporting Person under the Company's Amended and Restated 2019 Equity Incentive Plan on September 9, 2022, which vested based on the Issuer's achievement of corporate performance objectives.
F2 These shares were withheld from the vesting of a performance-based RSU award to cover the estimated tax withholding obligation.